Whether you're assigning random shifts, anonymizing a study, or shuffling a deck, randomizing rows in an Excel table manually ...
FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...
Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
Yes, this is an inspiring story of someone who took control of his health and his life. But just as important, it is further ...
Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
The CDC first recommended annual flu shots for all children 6 months and older in 2008, when it expanded the recommendation ...
Enliven Therapeutics jumped on strong ELVN-001 phase 1b CML data, but a rich valuation may cap upside. Click here to read an ...
Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...
A new meta-analysis finds no clear long-term cardiovascular benefit from beta-blockers after myocardial infarction in ...
Shares of Enliven Therapeutics (NASDAQ:ELVN) climbed 7% on Thursday after the company released positive early results from a ...